Pliant Therapeutics, Inc.
PLRX
$1.07
-$0.01-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.45% | -25.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.30% | -25.18% | |||
| Operating Income | -3.30% | 25.18% | |||
| Income Before Tax | 15.00% | 10.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.00% | 10.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.00% | 10.36% | |||
| EBIT | -3.30% | 25.18% | |||
| EBITDA | -3.84% | 25.32% | |||
| EPS Basic | 15.48% | 10.41% | |||
| Normalized Basic EPS | -3.52% | 26.58% | |||
| EPS Diluted | 15.48% | 10.41% | |||
| Normalized Diluted EPS | -3.52% | 26.58% | |||
| Average Basic Shares Outstanding | 0.58% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.58% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||